VWF and COVID-19: Complement is another potential enhancer of thrombosis, the membrane attack complex C5b-9 being increased in COVID-19–infected patients, in parallel with other endothelial activation markers such as von Willebrand factor, tissue plasminogen activator, and plasminogen activator inhibitor-1 (Cugno et al., 2020).